Avantax Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Avantax şirketinin toplam hissedar öz sermayesi $403.7M ve toplam borcu $278.1M olup, bu da borç-öz sermaye oranını 68.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $825.7M ve $422.0M dir. Avantax 'in FAVÖK'ü $41.0M faiz karşılama oranı 3.3 dur. Şirketin $106.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

68.9%

Borç/özkaynak oranı

US$278.07m

Borç

Faiz karşılama oranı	3.3x
Nakit	US$106.44m
Eşitlik	US$403.69m
Toplam yükümlülükler	US$421.99m
Toplam varlıklar	US$825.68m

Son finansal sağlık güncellemeleri

Recent updates

Shareholders Are Thrilled That The Blucora (NASDAQ:BCOR) Share Price Increased 154%

Feb 19

Read This Before Selling Blucora, Inc. (NASDAQ:BCOR) Shares

Nov 30

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AVTA 'nin kısa vadeli varlıkları ( $186.2M ) kısa vadeli yükümlülüklerini ( $89.8M ) aşıyor.

Uzun Vadeli Yükümlülükler: AVTA 'un kısa vadeli varlıkları ( $186.2M ) uzun vadeli yükümlülüklerini ( $332.2M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AVTA 'nin net borç/öz sermaye oranı ( 42.5% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: AVTA şirketinin borç/öz sermaye oranı son 5 yılda 40.3% seviyesinden 68.9% seviyesine yükseldi.

Borç Kapsamı: AVTA 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: AVTA 'in borcuna ilişkin faiz ödemeleri EBIT ( 3.3 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Avantax Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Avantax, Inc. Files Form 15

Recent updates

Avantax, Inc. Files Form 15

Avantax, Inc.(NasdaqGS:AVTA) dropped from S&P Composite 1500

Aretec Group, Inc. completed the acquisition of Avantax, Inc. (NasdaqGS:AVTA) from a group of shareholders.

Aretec Group, Inc. completed the acquisition of Avantax, Inc. (NasdaqGS:AVTA) from a group of shareholders.

Consensus EPS estimates fall by 43%

New major risk - Financial position

Third quarter 2023 earnings: EPS misses analyst expectations

Price target decreased by 8.0% to US$28.67

Aretec Group, Inc. entered into an agreement to acquire Avantax, Inc. (NasdaqGS:AVTA) for $960 million.

New major risk - Financial position

Second quarter 2023 earnings: EPS misses analyst expectations

Avantax, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Avantax Reportedly Working with Adviser to Explore Possible Sale

President exercised options and sold US$128k worth of stock

Avantax Promotes Jennifer Hutchins to Co-Chief Investment Officer

Avantax, Inc. Appoints Bruce Tuckey and Dave Renko as Regional Recruiting Director

Avantax, Inc. Provides Earnings Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Insider recently sold US$247k worth of stock

Avantax, Inc. Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings released: EPS: US$0.065 (vs US$0.16 in FY 2021)

Avantax, Inc. Appoints Melissa Loner as Chief Compliance Officer

Avantax, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Avantax, Inc. Announces Executive Changes

DS Admiral Bidco, LLC acquired TaxACT Holdings, Inc. from Blucora, Inc. (NasdaqGS:BCOR).

Blucora, Inc. (NasdaqGS:BCOR) announces an Equity Buyback for $450 million worth of its shares.

Independent Director recently bought US$119k worth of stock

Price target increased to US$29.00

High number of new directors

Price target increased to US$28.00

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

DS Admiral Bidco, LLC entered into a Stock Purchase Agreement to acquire TaxACT Holdings, Inc. from Blucora, Inc. (NasdaqGS:BCOR) for approximately $720 million.

Consensus forecasts updated

Blucora, Inc. Provides Earnings Guidance for the Year Ending December 31, 2022

Second quarter 2022 earnings: EPS exceeds analyst expectations

Blucora, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Blucora, Inc.(NasdaqGS:BCOR) dropped from Russell 2000 Value Index

Consensus forecasts updated

Consensus forecasts updated

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Blucora, Inc. Provides Earnings Guidance for the Full Year of Fiscal Year 2022

High number of new directors

Blucora, Inc. to Report Q1, 2022 Results on May 04, 2022

High number of new directors

President of Wealth Management exercised options to buy US$253k worth of stock.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Blucora, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2022

Blucora, Inc. to Report Q4, 2021 Results on Feb 16, 2022

Independent Director recently bought US$825k worth of stock

Third quarter 2021 earnings released: US$0.57 loss per share (vs US$0.55 loss in 3Q 2020)

Price target increased to US$25.33

Independent Director John MacIlwaine has left the company

Independent Director John MacIlwaine has left the company

Ancora Holdings Issues Letter to the Board of Directors of Blucora

Second quarter 2021 earnings released: EPS US$0.65 (vs US$1.04 in 2Q 2020)

Blucora, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2021

Blucora: Investor Day Highlights Improved Medium-Term Outlook

Price target increased to US$23.00

Consensus EPS estimates increase to -US$0.10

Blucora, Inc. Updates Earnings Outlook for the Second Quarter and Full Year 2021

Blucora forecasts Q2 and FY21 EPS above estimates

First quarter 2021 earnings released: EPS US$0.57 (vs US$6.60 loss in 1Q 2020)

Blucora, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal Year 2021

Blucora EPS beats by $0.08, misses on revenue

Blucora, Inc., Annual General Meeting, Apr 21, 2021

New 90-day high: US$17.97

Blucora Announces Appointment of Tina Perry to the Board of Directors

Shareholders Are Thrilled That The Blucora (NASDAQ:BCOR) Share Price Increased 154%

Full year 2020 earnings released: US$7.14 loss per share (vs US$1.00 profit in FY 2019)

Revenue and earnings beat expectations

New 90-day high: US$17.48

Blucora, Inc. to Report Q4, 2020 Results on Feb 17, 2021

New 90-day high: US$16.60

New 90-day high: US$16.04